1. Таточенко В.К. Антибиотики в арсенале участкового педиатра для лечения болезней органов дыхания. Лечащий врач. 2009; 6: 5–8.
2. Goossens H, Ferech M, Vander Stichele R, Elseviers M; ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365: 579–87.
3. Sommet A, Sermet C, Boelle PY et al. No significant decrease in antibiotic use from 1992 to 2000, in the French community. J Antimicrob Chemother 2004; 54: 524–8.
4. Armuzzi A, Cremonini F, Bartolozzi F et al. The effect of oral administration of Lactobacillus GG on antibiotic-associated ga­strointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2001; 15: 163–9.
5. Thomas MR, Litin SC, Osmon DR et al. Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trial. Mayo Clin Proc 2001; 76: 883–9.
6. Barbut F, Meynard JL. Managing antibiotic associated diarrhoea. BMJ 2002; 324: 1345–6.
7. McFarland LV. Epidemiology, risk factors and treatments for antibiotic-associated diarrhea [review]. Dig Dis 1998; 16: 292–307.
8. Wistrom J, Norrby SR, Myhre EB et al. Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother 2001; 47: 43–50.
9. LaRosa M, Bottaro G, Gulino N et al. Prevention of antibiotic-associated diarrhea with Lactobacillus sporogens and fructo-oligosaccharides in children: a multi-centric double-blind vs. placebo study. Minerva Pediatr 2003; 55: 447–52.
10. Turck D, Bernet JP, Marx J et al. Incidence and risk factors for of oral antibiotic-associated diarrhea in an outpatient pediatric population. J Pediatr Gastroenterol Nutr 2003; 37: 22–6.
11. Ивашкин В.Т., Шептулин А.А. Синдром диареи. М.: ГЭОТАР-Медицина, 2000; с. 135.
12. Бабаян М.Л. Современные методы профилактики антибиотикоассоциированных диарей у детей. Рус. мед. журн. 2005; 13 (8): 1206–7.
13. Lewis SJ, Potts LF, Barry RE. The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients. J Infect 1998; 36: 171–4.
14. Hogenauer C, Hammer HF, Krejs GJ, Reisinger EC. Mechanism and management of antibiotic-associated diarrhoea. Clin Infect Dis 1998; 27: 702–10.
15. Boyce JM, Havill NL. Nosocomial antibiotic-associated diarrhea associated with enterotoxin-producing strains of methicillin-resistant Staphylococcus aureus. Am J Gastroenterol 2005; 100 (8): 1828–34.
16. Ayyagari A, Agarwal J, Garg A. Antibiotic associated diarrhoea: Infectious causes. Indian J Med Microbiol 2003; 21 (1): 6–11.
17. Barlett JG. Antibiotic-associated diarrhoea. N Engl J Med 2002; 346: 334–9.
18. Edlund C, Nord CE. Effect on the human normal microflora of oral antibiotics for treatment of urinary tract infection. J Antimic­rob Chemother 2000; 46 (Suppl. S1): 41–1.
19. Surawicz CM. Probiotics, antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in humans. Best Pract Res Clin Gastroenterol 2003; 17: 775–83.
20. D’Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 2002; 324: 1361–4.
21. Cremonini F, Di Caro S, Nista EC et al. Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2002; 16: 1461–7.
22. Szajewska H, Mrukowicz J. Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea. Aliment Pharmacol Ther 2005; 22: 365–72.
23. Hawrelak JA, Whitten DL, Myers SP. Is Lactobacillus rhamnosus GG effective in preventing the onset of antibiotic-associated diarrhoea: a systematic review. Digestion 2005; 72: 51–6.
24. Johnston B, Supina A, Vohra S. Probiotics for pediatric antibio­tic-associated diarrhea: a meta-analysis of randomized placebo-controlled trials. CMAJ 2006; 175 (4): 377–83.
25. Arvola T, Laiho K, Torkkeli S et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics 1999; 104: e64.
26. Vanderhoof JA, Whitney DB, Antonson DL et al. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr 1999; 135: 564–8.
27. Cremonini F, Di Caro S, Covino M et al. Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 2002; 97: 2744–9.
28. McFarland LV, Surawicz CM, Greenberg RN et al. Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am J Gastroenterol 1995; 90: 439–48.
29. Захарова И.Н., Мумладзе Э.Б., Свинцицкая В.И. и др. Пробиотики в профилактике антибиотик-ассоциированных диарей у детей. Практика педиатра. 2009; 2: 32–6.
30. Маев И.В., Ивашкина Н.Ю., Самсонов А.А. и др. Возможности профилактики идиопатической антибиотикоассоциированной диареи у взрослых. Рос. журн. гастроэнтерологии, гепатологии, колопроктологии. 2009; 2: 75–8.
31. Учайкин В.Ф. и др. Профилактическая и терапевтическая эффективность аципола при антибиотико-ассоциированной диареи у детей. Дет. инфекции. 2009; 1: 44–7.
32. Олейниченко Е.В., Митрохин С.Д., Ноников В.Е., Минаев В.И. Эффективность аципола в профилактике дисбактериоза кишечника при антибактериальной терапии. Антибиотики и химиотерапия. 1999; 1: 23–5.

А.В.Горелов, Д.В.Усенко, А.А.Плоскирева

ФБУН Центральный НИИ эпидемиологии Роспотребнадзора, Москва